AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 98 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.12 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,671,000 | -44.3% | 1,978,723 | +5.5% | 0.19% | +2.2% |
Q4 2018 | $3,000,000 | -63.0% | 1,875,000 | -23.5% | 0.18% | -65.4% |
Q3 2018 | $8,109,000 | +19.6% | 2,449,800 | -18.3% | 0.53% | +14.8% |
Q2 2018 | $6,780,000 | -6.5% | 3,000,000 | +20.0% | 0.46% | -28.5% |
Q1 2018 | $7,250,000 | +3.9% | 2,500,000 | 0.0% | 0.64% | +9.0% |
Q4 2017 | $6,975,000 | -24.0% | 2,500,000 | -0.6% | 0.59% | -39.1% |
Q3 2017 | $9,183,000 | +23.8% | 2,515,810 | -24.7% | 0.96% | -11.7% |
Q2 2017 | $7,419,000 | +282.2% | 3,341,750 | +1.6% | 1.09% | +261.9% |
Q1 2017 | $1,941,000 | +259.4% | 3,290,000 | +229.0% | 0.30% | +694.7% |
Q4 2016 | $540,000 | – | 1,000,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 20,896,038 | $33,434,000 | 1.33% |
X-Square Capital, LLC | 270,680 | $433,000 | 0.34% |
Granahan Investment Management | 2,508,261 | $4,013,000 | 0.28% |
683 Capital Management, LLC | 1,875,000 | $3,000,000 | 0.18% |
New Leaf Venture Partners, L.L.C. | 402,118 | $643,000 | 0.18% |
Caption Management, LLC | 855,000 | $1,366,000 | 0.11% |
Private Portfolio Partners LLC | 51,000 | $82,000 | 0.05% |
Evercore Wealth Management, LLC | 418,414 | $669,000 | 0.02% |
Fosun International Ltd | 206,491 | $335,000 | 0.02% |
EXCALIBUR MANAGEMENT CORP | 11,000 | $18,000 | 0.02% |